Aurora signs technical services agreement with Australia’s Cann Group
Agreement scheduled to conclude at the end of 2022.
VANCOUVER and MELBOURNE, Australia — Aurora Cannabis Inc. and Melbourne-based Cann Group Ltd. have entered into a technical services agreement to exchange information and support on the cultivation and processing of medical cannabis, extraction and manufacturing technology, and analysis of cannabis extracts.
Aurora is Canada’s second largest publicly listed medical cannabis producer and the first Canadian company to establish purpose built cultivation facilities. It is a 19.9% shareholder of Cann.
Cann Chairman Allan McCallum said the agreement with Aurora will provide critical technical support as Cann proceeds with the expansion of its research and development and cultivation facilities in Melbourne.
“This agreement will facilitate close co-operation and valuable technical support as we continue to develop our business in the Australian market. The agreement with Aurora strengthens our R&D programs, cultivation, manufacturing and service to patients, and we believe will help us build strong brand equity in the Australian market,” he said.
Cann Group is focused on breeding, cultivating and manufacturing medical cannabis for sale and use in Australia, with research and cultivation facilities in Melbourne. It was the first company to be issued ith Australia’s first medical cannabis research license in February.
Aurora Cannabis Enterprises Inc. operates a 55,200 square foot production facility in Mountain View County, Alta. The company is currently building a second 800,000 square foot production facility, known as “Aurora Sky”, at the Edmonton International Airport, and has acquired, and is undertaking completion of, a third 40,000 square foot production facility in Pointe-Claire, Que., on Montreal’s West Island.